ELADYNOS Theramex Australia Pty Ltd
Product name
ELADYNOS
Sponsor
Accepted date
Jan-2024
Active ingredients
abaloparatide
Proposed indication
For the treatment of osteoporosis in postmenopausal women at increased risk of fracture.
Application type
A (new medicine)
Publication date
Jan-2024